Fibrosis is a chronic and progressive disorder characterized by excessive deposition of
extracellular matrix, which leads to scarring and loss of function of the affected organ or …

Transitory phenotypic changes such as the epithelial–mesenchymal transition (EMT) help
embryonic cells to generate migratory descendants that populate new sites and establish …

Peritoneal fibrosis is characterized by abnormal production of extracellular matrix proteins
leading to progressive thickening of the submesothelial compact zone of the peritoneal …

Peritoneal dialysis (PD) is a renal replacement therapy for patients with end-stage renal
disease that is equivalent to hemodialysis with respect to adequacy, mortality, and other …

Peritoneal dialysis is a form of renal replacement alternative to the hemodialysis. During this
treatment, the peritoneal membrane acts as a permeable barrier for exchange of solutes and …

Peritoneal dissemination is a frequent metastatic route for cancers of the ovary and
gastrointestinal tract. Tumour cells metastasize by attaching to and invading through the …

The blood-brain barrier (BBB) has a major role in maintaining brain homeostasis through the
specialized function of brain endothelial cells (BECs). Inflammation of the BECs and loss of …

Peritoneal adhesions (PAs) are fibrotic bands formed between bowel loops, solid organs,
and the parietal peritoneum, which may appear following surgery, infection or …

Peritoneal dialysis (PD) is a form of renal replacement therapy whose repeated use can alter
dialytic function through induction of epithelial–mesenchymal transition (EMT) and fibrosis …

Peritoneal dialysis (PD) is a therapeutic option for the treatment of end‐stage renal disease
and is based on the use of the peritoneum as a semipermeable membrane for the exchange …